Trial intelligence / Profile preview

Tranexamic Acid in Total Knee Arthroplasty

NCT02286973Phase 1Unknown

Sponsor
Seoul National University Hospital
Start
Nov 2014
Primary completion
Apr 2015
Modality
Small Molecules
01

Overview

Phase 1, randomised, double-blind trial of tranexamic acid in hemorrhage (4 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change in Hemoglobin at 5 days. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT02286973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02286973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call